Antifibrotic Therapies

Antifibrotic therapies are treatments designed to prevent or reduce scarring (fibrosis) in organs such as the lungs, liver, or skin. Fibrosis occurs when excess connective tissue builds up due to injury or inflammation, impairing organ function. These therapies work by targeting the biological pathways that promote scar tissue formation, helping to slow or stop this process. They are used in conditions like pulmonary fibrosis or liver cirrhosis to preserve organ health and improve quality of life. While not cures, antifibrotic medications aim to manage disease progression and prevent further damage.